Institutional shares held 25.8 Million
978K calls
295K puts
Total value of holdings $62.6M
$2.38M calls
$716K puts
Market Cap $105M
43,334,900 Shares Out.
Institutional ownership 59.49%
# of Institutions 125


Latest Institutional Activity in CRDF

Top Purchases

Q2 2025
Laurion Capital Management LP Shares Held: 1.8M ($4.37M)
Q2 2025
Blair William & CO Shares Held: 2.52M ($6.13M)
Q2 2025
Vanguard Group Inc Shares Held: 3.73M ($9.06M)
Q2 2025
Millennium Management LLC Shares Held: 1.13M ($2.74M)
Q2 2025
Two Sigma Investments, LP Shares Held: 444K ($1.08M)

Top Sells

Q2 2025
Jacobs Levy Equity Management, Inc Shares Held: 92.3K ($224K)
Q2 2025
Nuveen, LLC Shares Held: 560K ($1.36M)
Q2 2025
Gsa Capital Partners LLP Shares Held: 130K ($315K)
Q2 2025
Marshall Wace, LLP Shares Held: 299K ($726K)
Q2 2025
Dauntless Investment Group, LLC Shares Held: 5K ($12.2K)

About CRDF

Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; metastatic colorectal cancer that is in clinical trials; and TROV-054 is a Phase 1b/2 for FOLFIRI and bevacizumab. The company's TROV-053 is also in Phase II clinical trial in combination with Zytiga for metastatic castration-resistant prostate cancer. The company primarily serves pharmaceutical manufacturers. The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2012. Cardiff Oncology, Inc. was incorporated in 1999 and is headquartered in San Diego, California.


Insider Transactions at CRDF

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
669K Shares
From 3 Insiders
Open market or private purchase 669K shares
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on CRDF

Follow Cardiff Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRDF shares.

Notify only if

Insider Trading

Get notified when an Cardiff Oncology, Inc. insider buys or sells CRDF shares.

Notify only if

News

Receive news related to Cardiff Oncology, Inc.

Track Activities on CRDF